These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 15904919)

  • 1. Interaction between tau and alpha-synuclein proteins is impaired in the presence of P301L tau mutation.
    Benussi L; Ghidoni R; Paterlini A; Nicosia F; Alberici AC; Signorini S; Barbiero L; Binetti G
    Exp Cell Res; 2005 Aug; 308(1):78-84. PubMed ID: 15904919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initiation and synergistic fibrillization of tau and alpha-synuclein.
    Giasson BI; Forman MS; Higuchi M; Golbe LI; Graves CL; Kotzbauer PT; Trojanowski JQ; Lee VM
    Science; 2003 Apr; 300(5619):636-40. PubMed ID: 12714745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From genetics to pathology: tau and alpha-synuclein assemblies in neurodegenerative diseases.
    Goedert M; Spillantini MG; Serpell LC; Berriman J; Smith MJ; Jakes R; Crowther RA
    Philos Trans R Soc Lond B Biol Sci; 2001 Feb; 356(1406):213-27. PubMed ID: 11260802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. alpha-Synuclein and its disease-related mutants interact differentially with the microtubule protein tau and associate with the actin cytoskeleton.
    Esposito A; Dohm CP; Kermer P; Bähr M; Wouters FS
    Neurobiol Dis; 2007 Jun; 26(3):521-31. PubMed ID: 17408955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Following the leader: fibrillization of alpha-synuclein and tau.
    Frasier M; Wolozin B
    Exp Neurol; 2004 Jun; 187(2):235-9. PubMed ID: 15144849
    [No Abstract]   [Full Text] [Related]  

  • 6. Beta-amyloid treatment of two complementary P301L tau-expressing Alzheimer's disease models reveals similar deregulated cellular processes.
    David DC; Ittner LM; Gehrig P; Nergenau D; Shepherd C; Halliday G; Götz J
    Proteomics; 2006 Dec; 6(24):6566-77. PubMed ID: 17111439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FTDP-17 missense mutations site-specifically inhibit as well as promote dephosphorylation of microtubule-associated protein tau by protein phosphatases of HEK-293 cell extract.
    Han D; Paudel HK
    Neurochem Int; 2009 Jan; 54(1):14-27. PubMed ID: 18992292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frontotemporal dementia with tau pathology.
    Gasparini L; Terni B; Spillantini MG
    Neurodegener Dis; 2007; 4(2-3):236-53. PubMed ID: 17596718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No evidence for tau duplications in frontal temporal dementia families showing genetic linkage to the tau locus in which tau mutations have not been found.
    Johnson J; Ostojic J; Lannfelt L; Glaser A; Basun H; Rogaeva E; Kawarai T; Bruni A; St George Hyslop PH; Goate A; Pastor P; Chakraverty S; Norton J; Morris JC; Hardy J; Singleton A
    Neurosci Lett; 2004 Jun; 363(2):99-101. PubMed ID: 15172093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of tau pathologies in gray and white matter of Guam parkinsonism-dementia complex.
    Winton MJ; Joyce S; Zhukareva V; Practico D; Perl DP; Galasko D; Craig U; Trojanowski JQ; Lee VM
    Acta Neuropathol; 2006 May; 111(5):401-12. PubMed ID: 16609851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interface between tauopathies and synucleinopathies: a tale of two proteins.
    Galpern WR; Lang AE
    Ann Neurol; 2006 Mar; 59(3):449-58. PubMed ID: 16489609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caspase-cleaved tau accumulation in neurodegenerative diseases associated with tau and alpha-synuclein pathology.
    Newman J; Rissman RA; Sarsoza F; Kim RC; Dick M; Bennett DA; Cotman CW; Rohn TT; Head E
    Acta Neuropathol; 2005 Aug; 110(2):135-44. PubMed ID: 15986225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heat shock prevents alpha-synuclein-induced apoptosis in a yeast model of Parkinson's disease.
    Flower TR; Chesnokova LS; Froelich CA; Dixon C; Witt SN
    J Mol Biol; 2005 Sep; 351(5):1081-100. PubMed ID: 16051265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological features of the tauopathies.
    Murray B; Lynch T; Farrell M
    Biochem Soc Trans; 2005 Aug; 33(Pt 4):595-9. PubMed ID: 16042552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural and microtubule binding properties of tau mutants of frontotemporal dementias.
    Fischer D; Mukrasch MD; von Bergen M; Klos-Witkowska A; Biernat J; Griesinger C; Mandelkow E; Zweckstetter M
    Biochemistry; 2007 Mar; 46(10):2574-82. PubMed ID: 17297915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional genomics dissects pathomechanisms in tauopathies: mitosis failure and unfolded protein response.
    Götz J; David D; Hoerndli F; Ke YD; Schonrock N; Wiesner A; Fath T; Bokhari L; Lim YA; Deters N; Ittner LM
    Neurodegener Dis; 2008; 5(3-4):179-81. PubMed ID: 18322384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy.
    Höglinger GU; Lannuzel A; Khondiker ME; Michel PP; Duyckaerts C; Féger J; Champy P; Prigent A; Medja F; Lombes A; Oertel WH; Ruberg M; Hirsch EC
    J Neurochem; 2005 Nov; 95(4):930-9. PubMed ID: 16219024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hereditary Pick's disease with the G272V tau mutation shows predominant three-repeat tau pathology.
    Bronner IF; ter Meulen BC; Azmani A; Severijnen LA; Willemsen R; Kamphorst W; Ravid R; Heutink P; van Swieten JC
    Brain; 2005 Nov; 128(Pt 11):2645-53. PubMed ID: 16014652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. alpha-Synuclein: a potent inducer of tau pathology.
    Geddes JW
    Exp Neurol; 2005 Apr; 192(2):244-50. PubMed ID: 15755542
    [No Abstract]   [Full Text] [Related]  

  • 20. Characterization of alpha-synuclein aggregation and synergistic toxicity with protein tau in yeast.
    Zabrocki P; Pellens K; Vanhelmont T; Vandebroek T; Griffioen G; Wera S; Van Leuven F; Winderickx J
    FEBS J; 2005 Mar; 272(6):1386-400. PubMed ID: 15752356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.